BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 17687918)

  • 41. Ocular manifestations in systemic lupus erythematosus.
    Silpa-archa S; Lee JJ; Foster CS
    Br J Ophthalmol; 2016 Jan; 100(1):135-41. PubMed ID: 25904124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extensive medium-vessel vasculitis with SLE: an unusual association.
    Kumar N; Choudhary N; Agarwal G; Rizvi Y; Kaul B; Ahlawat R
    J Clin Rheumatol; 2007 Jun; 13(3):140-2. PubMed ID: 17551380
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bilateral Retinal Vasculitis as Initial Presentation of Systemic Lupus Erythematosus with Secondary Antiphospholipid Syndrome.
    Aldhefeery N; Alhadhood N; Alkadi A
    Am J Case Rep; 2023 Nov; 24():e942085. PubMed ID: 38013402
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ocular Manifestations in Rheumatoid Arthritis, Connective Tissue Disease, and Vasculitis: A Systematic Review and Metaanalysis.
    Turk MA; Hayworth JL; Nevskaya T; Pope JE
    J Rheumatol; 2021 Jan; 48(1):25-34. PubMed ID: 32358156
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ocular manifestations of rheumatoid arthritis.
    Reddy AK; Kolfenbach JR; Palestine AG
    Curr Opin Ophthalmol; 2022 Nov; 33(6):551-556. PubMed ID: 36165413
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of depressive and anxiety disorders in systemic lupus erythematosus and their association with anti-ribosomal P antibodies.
    Nery FG; Borba EF; Viana VS; Hatch JP; Soares JC; Bonfá E; Neto FL
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):695-700. PubMed ID: 18077068
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical and immunological features of retinal vasculitis in systemic diseases.
    Paović J; Paović P; Vukosavljević M
    Vojnosanit Pregl; 2009 Dec; 66(12):961-5. PubMed ID: 20095515
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Parvovirus B19 infection and systemic lupus erythematosus: Activation of an aberrant pathway?
    Aslanidis S; Pyrpasopoulou A; Kontotasios K; Doumas S; Zamboulis C
    Eur J Intern Med; 2008 Jul; 19(5):314-8. PubMed ID: 18549931
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ocular Manifestations of Antiphospholipid Syndrome in Jordan.
    Al-Zubi K; Sarayrah F
    Middle East Afr J Ophthalmol; 2022; 29(4):205-208. PubMed ID: 38162563
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An unusual presentation of systemic lupus erythematosus.
    Somasundaram KV; Sudhakar MK; Damodharan J; Kallarakkal JT; Sahib K; Mahajan A
    J Indian Med Assoc; 2004 Feb; 102(2):97, 99. PubMed ID: 15200204
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Myeloid leukaemia in systemic lupus erythematosus--a nested case-control study based on Swedish registers.
    Löfström B; Backlin C; Sundström C; Hellström-Lindberg E; Ekbom A; Lundberg IE
    Rheumatology (Oxford); 2009 Oct; 48(10):1222-6. PubMed ID: 19608725
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison between familial and sporadic systemic lupus erythematosus in Kuwaiti patients.
    Abutiban F; Mokkaddam K; Ameen E; Moussa M; Alsaeid K
    Lupus; 2009 Jan; 18(1):86-91. PubMed ID: 19074175
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systemic lupus erythematosus: An update for ophthalmologists.
    Papagiannuli E; Rhodes B; Wallace GR; Gordon C; Murray PI; Denniston AK
    Surv Ophthalmol; 2016; 61(1):65-82. PubMed ID: 26197421
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Lupus nephritis as a factor of atherosclerosis risk in patients with systemic lupus erythematosus].
    Serikova SIu; Kozlovskaia NL; Shilov EM
    Ter Arkh; 2008; 80(6):52-8. PubMed ID: 18655477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lupus aortitis leading to aneurysmal dilatation in the aortic root and ascending aorta.
    Brinster DR; Grizzard JD; Dash A
    Heart Surg Forum; 2009 Apr; 12(2):E105-8. PubMed ID: 19383583
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cutaneous lupus erythematosus: issues in diagnosis and treatment.
    Walling HW; Sontheimer RD
    Am J Clin Dermatol; 2009; 10(6):365-81. PubMed ID: 19824738
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Choroidal vascular occlusion].
    Märker DA; Walter A; Helbig H
    Ophthalmologe; 2011 Jan; 108(1):64-7. PubMed ID: 20535475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Meningioma and systemic lupus erythematosus: a matter of pure coincidence?
    Castellino G; Rizzo N; Bernardi S; Trotta F; Govoni M
    Lupus; 2009 Jun; 18(7):650-4. PubMed ID: 19433467
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe.
    Cervera R; Khamashta MA; Hughes GR
    Lupus; 2009 Sep; 18(10):869-74. PubMed ID: 19671784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.